Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
191
Frequently Asked Questions
What is Market Cap of Dyne Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dyne Therapeutics Inc market cap is $1.89B.
What is the 52-week high for Dyne Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dyne Therapeutics Inc 52 week high is $37.08 as of September 12, 2025.
What is the 52-week low for Dyne Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dyne Therapeutics Inc 52 week low is $6.36 as of September 12, 2025.
What is Dyne Therapeutics Inc stock price today?
Dyne Therapeutics Inc stock price today is $13.18.
What was Dyne Therapeutics Inc stock price yesterday?
Dyne Therapeutics Inc stock price yesterday was $13.28.
What is the PE ratio of Dyne Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dyne Therapeutics Inc’s P/E ratio is -3.44.
What is the Price-to-Book ratio of Dyne Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dyne Therapeutics Inc P/B ratio is 2.6572.
What is the 50-day moving average of Dyne Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dyne Therapeutics Inc 50-day moving average is $10.94.
How many employess does Dyne Therapeutics Inc has?